Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.
Cost of Care
Posted inCost of Care
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith. d
Posted inCost of Care
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.
Posted inCost of Care
Pain, Fear and Waste: The Costs of Unnecessary Care
We explore cascades of care — how a clinician’s desire to be thorough can snowball into a harmful spiral of unnecessary care.
Posted inCost of Care
Ways to Save in Budget Busting Medicare Part B
Stacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.
Posted inHealth Law
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Posted inCost of Care
State AGs Are Doing Work on Drug Pricing
Erin Fuse Brown writes about a new article highlighting the role of state attorneys general on improving drug price affordability.
Posted inCost of Care
Saving Money on Cancer Care Is Hard
Stacie Dusetzina shares new research on the results of one of the largest efforts ever to improve care and control costs for cancer patients.
Posted inCost of Care
Let’s Make a Deal…on Drug Prices
Democrats are on the brink of passing a historic set of drug price reforms. How will they impact patients, insurers and the drug industry?
Posted inInsurance
Has Medicaid Managed Care Delivered On Its Promise?
Letting private insurers offer Medicaid coverage was supposed to lower costs and improve care. Did it work?